Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £26.93m
NMT Live PriceLast checked at - London Stock Exchange

Intraday Neometals Share Chart

Lithium Chemicals Update

21 Mar 2024 07:00

RNS Number : 7574H
Neometals Ltd
21 March 2024
 

21 March 2024

Neometals Ltd

("Neometals" or "the Company")

Lithium Chemicals Update

Highlights:

· Reed Advanced Materials (Neometals 70%, Mineral Resources 30%) and Lifthium Energy have ceased discussions in relation to updated arrangements for the evaluation of a lithium refinery in Portugal; and

· Reed Advanced Materials will sole fund the final stage of the pilot test work program for its patented ELi? process and will pursue a low-capital, low-risk technology licensing business model.

Sustainable process technology developer, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company") advises that its joint venture company, Reed Advanced Materials Pty Ltd ("RAM") (70% NMT, 30% Mineral Resources Ltd) has ceased discussions with Lifthium Energy SA ("Lifthium") in relation to updated arrangements for the further evaluation of a lithium refinery to produce lithium chemicals in Estarreja, Portugal. RAM will proceed to complete the final stage of pilot test work and intends to commercialise its proprietary ELi? process which comprises an extensive patented technology package through a licensing business model.

RAM has been co-funding evaluation activities with Bondalti Chemicals SA ("Bondalti") and negotiating a new co-operation framework with Bondalti's sister company, Lifthium.[i] RAM and Bondalti completed an Engineering Cost Study ("ECS") to AACE Class 3 standard for a 25,000tpa lithium hydroxide monohydrate merchant refinery in Portugal and have been advancing a phased pilot scale test work program in Canada ("Pilot").

The ECS confirmed the technical feasibility of the process to purify and convert lithium chloride to lithium hydroxide with potential lowest-quartile operating costs and capital cost intensity. Additionally, the first stage of the Pilot successfully purified lithium chloride from an existing South American operation to the specification required for conversion by electrolysis using ELi?[ii]. Despite the compelling operating / capital cost metrics and successful purification Pilot activities, RAM and Lifthium have been unable to agree terms for further joint evaluation activities and licensing arrangements. 

RAM is fully funded to complete the final stage of Pilot test work and will continue to test third-party brines for potential partners under a low-capex, low-risk technology licensing business model to generate future royalty income.

Neometals Managing Director Chris Reed said:

"Neometals appreciates the collaboration with Bondalti in advancing the commercialisation of our ELi? process. We are committed to the commercialisation of ELi? which we see as the future of sustainable low-cost lithium production from brines to meet the demands of the transport electrification and energy storage thematic. In light of the current price cycle, we will pivot towards a more conservative business model for commercialisation."

Authorised on behalf of Neometals by Christopher Reed, Managing Director.

ENDS

For more information, please contact:

 

Neometals Ltd

Chris Reed, Managing Director & Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus, General Manager - IP & IR

 +61 8 9322 1182

 

Cavendish Capital Markets Ltd - NOMAD & Joint Broker

 

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

 

About Neometals

Neometals is commercialising a portfolio of sustainable processing solutions that recycle and recover critical materials from high value waste streams. The Company collaborates with partners and customers to facilitate circular supply chains and reduce the environmental burden of traditional mining in the global transition to a sustainable economy. Neometals' three core business units are exploiting the technologies under principal, joint venture and licensing business models:

· Lithium-ion Battery ("LiB") Recycling (50% technology) - Commercialisation via Primobius GmbH JV (NMT 50% equity). All plants built by Primobius' co-owner (SMS group 50% equity), a 150-year-old German plant builder. Providing recycling service as principal in Germany and commenced plant supply and licensing activities as technology partner to Mercedes-Benz. Primobius targeting first commercial, fully integrated, 21,000tpa plant offer to Canadian company Stelco in the JunQ 2025;

· Lithium Chemicals (70% technology) - Commercialising patented ELi? electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Pilot scale test work and Engineering Cost Study update in progress. Commercialisation strategy is through technology licensing model; and

· Vanadium Recovery (100% technology) - aiming to enable sustainable production of high-purity vanadium pentoxide from processing of steelmaking by-product ("Slag") at lowest-quartile operating cost. Targeting partnerships with steel makers and participants in the vanadium chemical value chain under a low risk / low capex technology licensing business model.

For further information visit www.neometals.com.au

 


[i] For full details refer to Neometals ASX announcement titled "Lithium Chemicals Co-operation Update" dated 3 October 2023.

[ii] For full details refer to Neometals ASX announcements titled "Portugal Lithium Refinery Study Confirms Step-change Opex of ELi? Technology" dated 26 April 2023 and "Successful Eli Purification Pilot Trial" dated 10 November 2023.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGZFVMGGDZG
Date   Source Headline
3rd Feb 20257:00 amRNSCancellation - Neometals Ltd
23rd Jan 20257:01 amRNSQuarterly Activities Report
23rd Jan 20257:01 amRNSQuarterly Cashflow
17th Jan 20257:00 amRNSCancellation of Performance Rights
20th Dec 20247:00 amRNSProposed Cancellation of Admission to AIM
6th Dec 20247:00 amRNSDirector/PDMR Dealings
22nd Nov 20249:09 amRNSResult of Annual General Meeting
22nd Nov 20247:42 amRNSChairman’s AGM 2024 Address
18th Nov 20241:14 pmRNS2024 Annual General Meeting Broadcast
12th Nov 20247:00 amRNSPositive Results from ELi™ Pilot Trial
8th Nov 20249:24 amRNSDirector / PDMR Participation in Entitlement Offer
7th Nov 202410:16 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSResults of Entitlement Offer
24th Oct 20247:01 amRNSQuarterly Activities Report
24th Oct 20247:01 amRNSQuarterly Cashflow
22nd Oct 20247:00 amRNSMercedes Benz Plant Opening
21st Oct 20247:00 amRNSNotice of Annual General Meeting
21st Oct 20247:00 amRNSEntitlement Offer Opens
18th Oct 20247:00 amRNSDirector/PDMR Dealings
14th Oct 20249:49 amRNSPosting of Annual Report
11th Oct 20247:00 amRNSA$4 Million Placement and Entitlement Offer
9th Oct 20247:00 amRNSASX Trading Halt
30th Sep 20247:50 amRNSResult of EGM
26th Sep 20248:56 amRNSAnnual Financial Report
23rd Sep 20247:00 amRNSBarrambie Gold Exploration Target
20th Sep 20247:00 amRNSAGM Update
16th Sep 20247:00 amRNSVRP receives EU supported capital injection
27th Aug 202410:02 amRNSNotice of EGM
22nd Aug 20247:00 amRNSPrecious Metals Recovery Option Lapse
22nd Aug 20247:00 amRNSNeometals Strategy Update
19th Aug 20247:00 amRNSUS$3M Placement
16th Aug 20247:00 amRNSResults of Extraordinary General Meeting
7th Aug 20247:00 amRNSCorporate Presentation
30th Jul 20247:19 amRNSQuarterly Activities Report
30th Jul 20247:15 amRNSQuarterly Cashflow
17th Jul 20248:36 amRNSNotice of Extraordinary General Meeting
11th Jul 20247:12 amRNSAppointment of Company Secretary
9th Jul 20249:59 amRNSDirector/PDMR Dealings
4th Jul 202411:59 amRNSIssue of Shares
27th Jun 202410:26 amRNSDirector Change
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.